OS Therapies settles $10M Leonite note for $1.9M cash + 500k shares; issues $2.2M bridge note

OS Therapies Inc

On July 31, 2026, OS Therapies agreed to pay Leonite $1.9M cash and issue 500,000 shares to fully satisfy the $10M secured convertible note (only $1.6M drawn).
The settlement cancels the warrant to purchase 1.75M shares at $2.85 and 275,000 commitment shares; all security interests are released.
To fund the settlement, on Aug 2, 2026, the company issued a $2.2M bridge convertible note (purchase price $2.19M) to an accredited investor, maturing Sept 1, 2026.
The bridge note automatically converts into a future private offering of up to $10M; proceeds used for settlement and working capital.
Settlement expected to close by Aug 7, 2026; shares to be issued under effective S-3 registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.